Newsfiscal.ai
Eikon Therapeutics Announces Availability of Seven Abstracts for Presentation at the 2026 ESMO Congress
· Published
Article summary
Eikon Therapeutics has released seven full-text abstracts detailing clinical data for its oncology pipeline, which will be presented at the upcoming 2026 European Society for Medical Oncology (ESMO) Congress.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…